The Enterprise Value as of November 2024 (TTM) for Cogent Biosciences, Inc. (COGT) is 929.30M

According to Cogent Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 929.30M. This represents a change of 29.96% compared to the average of 715.05M of the last 4 quarters.

Cogent Biosciences, Inc. (COGT) Historical Enterprise Value (quarterly & annually)

How has COGT Enterprise Value performed in the past?

The mean historical Enterprise Value of Cogent Biosciences, Inc. over the last ten years is 119.90M. The current 929.30M Enterprise Value has changed 77.41% with respect to the historical average. Over the past ten years (40 quarters), COGT's Enterprise Value was at its highest in in the September 2024 quarter at 1.11B. The Enterprise Value was at its lowest in in the September 2020 quarter at -31540039.20.

Cogent Biosciences, Inc. (COGT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cogent Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cogent Biosciences, Inc. (COGT) Average Enterprise Value

How has COGT Enterprise Value performed in the past?

The current Enterprise Value of Cogent Biosciences, Inc. (COGT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Cogent Biosciences, Inc. (COGT) Enterprise Value vs. Peers

How is COGT’s Enterprise Value compared to its peers?

Cogent Biosciences, Inc.’s Enterprise Value is greater than Larimar Therapeutics, Inc. (363.34M), greater than Kura Oncology, Inc. (807.00M), less than Kiniksa Pharmaceuticals, Ltd. (1.45B), less than Cerevel Therapeutics Holdings, Inc. (8.24B), less than IDEAYA Biosciences, Inc. (1.93B), greater than AnaptysBio, Inc. (502.56M), greater than MeiraGTx Holdings plc (427.31M), less than Keros Therapeutics, Inc. (1.75B), greater than Homology Medicines, Inc. (-103303255.00), greater than Sana Biotechnology, Inc. (551.82M), greater than Olema Pharmaceuticals, Inc. (468.89M), greater than Cullinan Oncology, Inc. (630.54M), greater than aTyr Pharma, Inc. (138.44M), greater than Zentalis Pharmaceuticals, Inc. (229.32M), less than Syndax Pharmaceuticals, Inc. (1.24B), greater than KalVista Pharmaceuticals, Inc. (468.87M), greater than Mersana Therapeutics, Inc. (204.64M), greater than Ventyx Biosciences, Inc. (80.09M), less than Protagonist Therapeutics, Inc. (2.65B), less than Verona Pharma plc (2.96B),

Build a custom stock screener for Cogent Biosciences, Inc. (COGT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cogent Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cogent Biosciences, Inc. (COGT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cogent Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.